www.biotransformationevent.com
Open in
urlscan Pro
78.137.168.141
Public Scan
Submitted URL: https://www.industryexpo.ie/mailster/1973/5d1ebdec0309cffc63e6f80b89b2f6b0/aHR0cHM6Ly93d3cuYmlvdHJhbnNmb3JtYXRpb25ldmVudC5jb20v
Effective URL: https://www.biotransformationevent.com/
Submission Tags: falconsandbox
Submission: On December 15 via api from US — Scanned from DE
Effective URL: https://www.biotransformationevent.com/
Submission Tags: falconsandbox
Submission: On December 15 via api from US — Scanned from DE
Form analysis
1 forms found in the DOMGET https://www.biotransformationevent.com/
<form method="get" id="searchform" class="form-search center-text" action="https://www.biotransformationevent.com/">
<label for="s" class="cfc-h-tx tt-upper">Type and Press “enter” to Search</label>
<input type="text" id="s" class="search-query cfc-h-tx center-text tt-upper" name="s">
</form>
Text Content
Biopharma & Lifesciences Connected Live January 25th 2023 Radisson Blu Hotel & Spa, Cork Register Free Contact us Navigation * Home * Agenda * Speakers * Exhibitors * Media * Partners * Video Gallery * Register * Contact * Accommodation * Search * Home * Agenda * Speakers * Exhibitors * Media * Partners * Video Gallery * Register * Contact * Accommodation * Search BioPharma & Lifesciences Connected Live January 25th 2023 | Radisson Blu Hotel & Spa, Cork REGISTER -------------------------------------------------------------------------------- Book you place at the Biopharma & Lifesciences Connected conference and exhibition to hear from leading national and international experts in pharmaceutical manufacturing. The biopharma sector in Ireland is experiencing significant challenges around supply chain issues, digital transformation, automation, carbon reduction and regulatory changes.. The central theme of this event is to hear directly from industry leaders and stakeholders who are willing to share challenges and solutions in practice. That means, the spotlight in presentations will be on case studies from pharmaceutical companies - allowing you to benefit from the speakers' experience in their everyday practice. Over 15 leading speakers involved in the development & manufacturing of biopharmaceutical & biotech products & technology will participate in a full day's schedule of keynote talks & panels on the topics shaping the sector. Why Attend * Listen to over 15 expert talks and panel debates on the latest industry issues facing the biopharma & biotech sector. * Avail of the excellent networking opportunities with peers throughout the day * Network with over 30 exhibitors displaying the latest technology and research * Meet with government support agencies and associations * Join our Q&A with industry thought leaders Key Topics Include * Research & Innovation * Automation * Vaccine Manufacturing * Process Optimization * Tech Transfer * Digitalization * IoT & Industry 4.0 * Covid 19 – Impact to the market * Hybrid Systems – Single Use and/or Stainless Steel * Biosimilars – Best-Practice * Ultrafast Project Execution * Turnkey * HVAC & Cleanroom Engineering * Cell & Gene Therapy Call for Speakers To speak, sponsor and or exhibit at the event please email info@biotransformationevent.com SPEAKERS CONFIRMED SIOBHAN FLEMING COLLABORATIONS MANAGER - BIOPHARMA DATA ANALYTICS - SIEMENS Speaker Bio Working in regulated industry for over 20 years, Siobhan has supported the implementation of new technologies across the pharmaceutical organisation. With Siemens Digital Industries she leads the BioMAC initiative between Siemens, NIBRT and industrial partners, using advanced data analytics to improve operations at all stages of the biopharmaceutical manufacturing lifecycle. CONOR MCALONAN SUPPLIER QUALITY ENGINEER - Speaker Bio Conor is a Supplier Quality Engineer focused on Single-Use Technology and vaccine manufacturing. He has received a Bbus. (Hons.) in Global Supply Chain Management from MTU and holds certifications in Medical Device Manufacturing, cGMP Validation and Chemistry, and Lean/Six Sigma. Prior to holding a role in the pharmaceutical industry, he was a Paratrooper in the US Army and had a 20-year career in the hospitality industry as a chef. He is passionate about digital transformation in supply chain and has spoken on topics covering both change management and diversity and inclusion. MATT MORAN DIRECTOR - BIOPHARMACHEM IRELAND "MAKE IRELAND THE GLOBAL LEADER IN SUSTAINABLE BIOPHARMACEUTICAL AND CHEMICAL MANUFACTURING – A STRATEGY FOR THE SECTOR 2023-27" Speaker Bio Matthew Moran is Director of BioPharmaChem Ireland. He graduated in Chemistry at Trinity College Dublin in 1980 and in Chemical Engineering at University College Dublin in 1981; he holds an MBA also from University College Dublin (Smurfit School of Business). He worked for over ten years in the pharmaceutical industry where he held a number of management positions both in active ingredient and dosage form manufacture. He is a member the European Chemical Industry Council (CEFIC). Matthew Moran is a Board member of the Active Pharmaceuticals Ingredients (API) Committee of CEFIC (CEFIC/APIC) and The European Association for Bioindustries (Europabio) BioPharmaChem Ireland represents the interests of the biopharmachem sector in Ireland. CEFIC/APIC represents the European API Industry. Europabio represents the European Biotech Sector. GERARD CARTON CEO & CO-FOUNDER - PLANTQUEST "DIGITAL TRANSFORMATION - FROM THE BOARDROOM TO THE PLANTROOM" Speaker Bio Synopsis Ger Carton is the co-founder and CEO of PlantQuest, a software company enabling some of the world’s largest BioPharma & Lifesciences companies to digitally transform their asset management operations. Prior to this Ger gained over two decades of experience working across a range of disciplines within the leading pharmaceutical, med devices, and oil & gas companies. No stranger to the challenges and opportunities faced in digitising process intensive facilities, Ger shares his learnings and experiences in the matter from both the perspective of the buyer and the vendor. In this talk Ger will focus on the challenge of transferring products and services as they are sold in the boardroom, to the real world use cases out in the Plant. Key points Ger will touch on are: The disconnect between new products and technologies, and the availability of the datasets needed to make them work. The managing of expectations around digital transformation in terms of technology, timelines and outcomes. How to plan for success in facility digital transformation PATRICK O'SULLIVAN DIRECTOR OF DATA & ANALYTICS - LIFE SCIENCE - EY "LEVERAGING DIGITAL CAPABILITIES TO CONNECT TO YOUR EXTERNAL SUPPLY CHAIN & CMOS" Speaker Bio Patrick is the Director of Life Science Data & Analytics at EY where he leads a dedicated team in supporting clients deliver value through data driven decision making and artificial intelligence. Patrick’s team works across all key areas of Life Science organisations such as Advanced Internal & External Manufacturing, Supply Chain, Procurement and Commercial Operations. Prior to joining EY Patrick worked at Johnson and Johnsons Pharmaceutical company Janssen where he supported, built and lead many of the recent global digital successes in their pharmaceutical business impacting a number of areas such as supply chain, manufacturing and procurement. Patrick’s work at J&J included defining common data strategies and enterprise deployment, integrating analytics and emerging technologies into manufacturing sites to stabilize/optimize the process leading to multi million euro savings through increased productivity and defining plant data strategies that supported achieving World Economic Forum Lighthouse status at two international sites. In addition, Patrick’s key work related to the rapid scaling up of the covid-19 vaccine by leading a team to enable live data connectivity with real time analytics from Contract Manufacturers. This critical work enabled live manufacturing visibility, inventory levels and product movement in which Patrick continued to scale this capability across J&Js Small and Large Molecule business to shift the external supply chain from a reactive to proactive approach. DARREN WOODS MANAGING DIRECTOR - WD EXCELLENCE "INSPIRE YOUR TEAM TO ACHIEVE OPERATIONAL EXCELLENCE" Speaker Bio Darren Woods is the Managing Director and co-founder of WD Excellence. Specialising in the Pharma and Biotech industry, WD Excellence is an energetic consulting company with a mission to guide organisations to new levels of performance. Darren is very focused on continuous learning, holding an MBS in Business Practice, an honours degree in Manufacturing Engineering, 3 post graduate diplomas and a Lean Six Sigma Black belt. Darren is passionate about all things Operational Excellence and has delivered significant transformations for manufacturing and R&D companies over the past 2 decades. Darren has had the pleasure of working with companies including MSD, Wuxi, Astellas, APC, VLE therapeutics, and Aerie Pharmaceuticals . ELÉONORE ASSAS SENIOR MSAT BIOMANUFACTURING ENGINEER - MERCK LIFE SCIENCE "CURRENT PRODUCT BEHAVIOUR TRENDS, IMPACT AND MITIGATION MEASURES FOR VIRAL FILTRATION AND VALIDATION" Speaker Bio Eléonore Assas is a Merck Senior Biomanufacturing Engineer (BME) based in Copenhagen (Denmark). She holds a Masters degree in Industrial and Mechanical Engineering and a Masters of Science in Biomedical Engineering from Arts et Metiers ParisTech in Paris, France. Initially coming from membrane manufacturing she then joined the Merck MSAT (Manufacturing Science And Technology) team and has a strong focus on viral filtration processes OWEN BUCKLEY HEAD OF CORPORATE PARTNERSHIPS - UNICEF IRELAND "UNICEF: LARGEST SINGLE VACCINE BUYER IN THE WORLD" TANER CHAKAR PRODUCT MANAGER - SKYCELL "COMPLEXITIES OF END-TO-END VISIBILITY OF YOUR SUPPLY CHAIN: WHY BOTH S-DATA AND O-DATA ARE NEEDED" Speaker Bio Synopsis Tanre is a product manager at SkyCell with more than 15 years in supply chain solutions. Together with his colleagues at SkyCell, they strive for only one thing: to provide sustainable solutions to pharma organizations to deliver medicines without any product loss. During the past two decades, the value of pharmaceutical goods traded globally has grown sixfold, from $113 billion in 2000 to $629 billion in 2019¹. As a result of this growth, supply chains have become increasingly global and complex. With $35B still lost annually as a result of failures in temperature-controlled logistics worldwide, it’s clear that there is room for improvement. In this talk, we would like to introduce a new definition of end-to-end visibility and discuss why simulation data (S-data) and operational data (O-data) are mandatory for making data-driven decisions. JOHN COBB GROUP MICROBIOLOGIST - PMT (UK) LTD "ANNEX 1 VIABLE MONITORING: CLASSICAL VERSUS REAL-TIME METHOD" Speaker Bio John is a GMP qualified Microbiologist with over 30 years of experience in Environmental Monitoring. He was part of an MHRA group selected to develop and validate the first irradiated agar plates to be used in Grade A GMP facilities. John has also been involved in the Design, Promotion and Validation of slit-to-agar active air samplers since 1985. He is a strong advocate of viable monitoring over an entire production run by classical agar based methods and real time methods. CLAIRE DALY TRAINING MANAGER - JANSSEN SCIENCES IRELAND PATRICK FALVEY PRINCIPAL CONSULTANT - LATHAM BIOPHARM GROUP "CDMO SELECTION STRATEGY AND PROCESS" Speaker Bio Patrick Falvey has over 30 years of research, managerial and technical experience in the Pharmaceutical and Biotechnology Industries. He has enjoyed various positions of responsibility and leadership in Operations, Quality Assurance, and Compliance and believes in collaboration among individuals and groups to effect positive change and improvement. Patrick has previously been a Senior Team Lead for Pfizer with responsibility for the manufacture of Prevnar 13 vaccine, (prevention of pneumococcal meningitis) one of the world’s most successful vaccines. He has hosted and responded to various agency audits including FDA, EMA, SFDA (China) and was responsible for overall Department Inspection Readiness program. He has led and been responsible for a team of Investigation and Compliance specialists that closed hundreds of investigations and commitments to maintain state of compliance. He has onboarded & designed GMP training programs for new college graduates for introduction to Aseptic & Cleaning Qualification programs to support multiple aseptic manufacturing lines and has managed site GMP Training/Safety programs. Patrick has worked with a variety of companies ranging from large pharmaceutical companies to start-up ventures. Patrick received his Bachelor of Science in Biochemistry from University College Cork in Ireland, Masters of Science (Industrial Pharmacy) from Long Island University in Brooklyn, and his Master of Business Administration from Iona College in New Rochelle NY. MARGOT HOLLAND SUPPLY CHAIN ANALYTICS SITE LEAD - JANSSEN SCIENCES IRELAND Speaker Bio Site Lead for Supply Chain Analytics in Janssen Sciences Ireland, Ringaskiddy and a core team member for the global Johnson & Johnson Analytics Team. Margot has over 24 years of experience across the Finance, Engineering, Pharmaceutical and IT industries. Prior to joining Janssen, Margot held technical and leadership roles in IBM, UCC, Motorola and Financial Services. In her current role she is focused on data science and analytics including predictive modelling, digital twins, natural language processing and decision optimisation. JP KELLY HEAD OF DEPARTMENT - CORK - MURPHY GEOSPATIAL "EFFECTIVE GEOSPATIAL STRATEGY TO REDUCE RISK AND DELAYS IN BIOPHARMA PROJECTS" Speaker Bio JP Kelly is Department Head at Murphy Geospatial Cork office. He qualified as a Geomatics Surveyor at TU Dublin in 1999 and later returned to TU Dublin in 2010 to add another degree to his name, this time in Quantity Surveying and Construction Economics. He started his career as a surveyor with Murphy Geospatial (formerly Murphy Surveys Ltd.) and then moved into the construction sector working as a project manager on a variety of civil and building projects in Ireland and the UK. JP returned to his Geospatial roots in 2012 when he re-joined Murphy Geospatial. Over the last 10 years, JP has successfully introduced cutting-edge BIM workflows and Geospatial Management plans on numerous prestigious high-tech and Pharmaceutical projects. By leading and enabling our brilliant Geospatial team in Cork, JP takes great pride in delivering industry-leading geospatial and surveying services to all of our valued customers in Cork, Munster and Europe. NIELS-ERIK KONGSTE VICE PRESIDENT SALES HIGH PURITY EUROPE - AAF EUROPE "MEMBRANE HEPA FILTRATION TO LIFE SCIENCE: HISTORY, PRESENT AND THE FUTURE" Speaker Bio Synopsis MSc Mechanical Engineer 30 years experience in the global HVAC and Air Filtration industry Specialist in HEPA filtration in especially the cleanroom & lifescience industry. Recent years additional focus on optimization related to energy savings and predictive maintenance programs. Membrane HEPA filtration or ePTFE (expanded PolyTetrafluoroEthylene) media which is the technically description of the material used in the membrane filter media has been on the market since the mid 1980 ́s. ePTFE fine fibers was initially developed by Daikin as part of their chemical division. This presentation will describe the early progress of the fine fiber technology and the development process of manufacturing commercially available filters throughout the 90 ́s until today where modern PTFE membrane HEPA filters are replacing the traditional microglass HEPA filters in the LifeSCience industry. ePTFE HEPA and especially ULPA (U15-U17) filters were quickly adopted by the semiconductors industry due to the superior mechanical stability and super low outgassing behavior and proven chemical compatibility compared to traditional microglass HEPA/ULPA filters. Today ePTFE membrane ULPA filters is the industry standard in the most critical process steps in the semiconductor industry. TERRI LOVE SENIOR MSAT BIOMANUFACTURING ENGINEER - MERCK LIFE SCIENCE "CURRENT PRODUCT BEHAVIOUR TRENDS, IMPACT AND MITIGATION MEASURES FOR VIRAL FILTRATION AND VALIDATION" Speaker Bio Terri Love is a Senior Biomanufacturing Engineer within the Manufacturing and Sciences Technology team at Merck KGaA, based in Ireland. Following a BSc degree in Industrial Biochemistry from the University of Limerick, Terri worked for Lonza Biologics in the UK before returning to Ireland to work with Merck. Terri has been employed within the biopharma industry for the past 21 years, and she has been working for 18 years as a field-based Biomanufacturing Engineer at Merck in Ireland. During her time at Merck, Terri has been collaborating with Irish biopharma customers on their technology transfers, scale-up and implementation DR. TRISH O'CONNELL LECTURER IN BIOPHARMACEUTICAL & MEDICAL MATHEMATICS & STATISTICS - ATLANTIC TECHNOLOGICAL UNIVERSITY "LEAN SIGMA AND ITS APPLICATION TO THE BIOPHARMA & LIFESCIENCES SECTOR." Speaker Bio Dr. Trish O’Connell is the academic coordinator of the Master of Science in Biopharmaceutical Manufacturing run by the Atlantic Technological University Galway city campus. Having come to academia from industry, she has extensive industrial experience at both senior and consulting engineer level in the application and use of statistical tools for manufacturing. Trish holds a Lean Six Sigma Black Belt and currently lectures to final year students on the BSc (Hons) in Applied Biology and Biopharmaceutical Science. She also lectures and supervises students on the level 9 Masters. MUKUNTH VENKATESAN FOUNDER, DIRECTOR & CEO - AGARAM TECHNOLOGIES "PAPERLESS SOLUTIONS FOR DATA INTEGRITY & COMPLIANCE IN BIOPHARMA" Speaker Bio Mukunth Venkatesan is the Founder, Director & CEO of Agaram Technologies. Agaram technologies is a leading provider of enterprise class laboratory solutions to regulated & non-regulated industries across the globe. Mukunth has a strong background in Applied Sciences & Biomedical instrumentation. He started his career as a Biomedical instrumentation engineer in 1990 following which, he joined the Agaram group in 1992 to lead the analytical instrumentation and R&D division for developing and manufacturing HPLCs in India. He then moved on to establish a software development team focused on solutions for analytical instrumentation. This move laid the foundation for the development of in-house Laboratory Informatics software products such as Qualis LIMS, Logilab ELN and Logilab SDMS that are now established solutions being used by Pharmaceutical and Life Sciences organisations across the globe. Mukunth has worked along with ASTM committee members for the development of the latest LIMS standard, delivered solutions for regulatory bodies and other reputed regulated organisations. Over the past 25 years , Agaram Technologies under the leadership of Mukunth has helped organizations involved in QC and R&D processes in laboratories to meet cGMP, Data Integrity, GxP, Regulatory Compliances such as US FDA 21 CFR Part 11, EudraLex annex 11, ISO 17025 and other industry standards. CHRISTIAN WITZ CEO & FOUNDER - SIMVANTAGE "ACCELERATING SCALE-UP WITH A NEXT-GENERATION SIMULATION SOFTWARE" Speaker Bio Synopsis Christian Witz did his Ph.D. in the group of Prof. Khinast at the Institute of Process and Particle Engineering on the topic of multiphase reactor simulation using the lattice Boltzmann method. He then established the Computational Bioprocess Engineering group at the institute to find, test, validate, and interconnect highly efficient algorithms for graphic processing units (GPUs) to simulate the physical process inside devices like the bioreactor. This in-house codebase is the basis for the spin-off SimVantage, which provides cloud-based simulation software and consulting for stirred and/or aerated reactors. With new numerical algorithms and powerful computer hardware, the first physical-principle simulation of (bio-)reactors in production sizes is now possible. With the lifelines concept, different reactor sizes or geometries can be compared based on the experience of the cells or microorganisms in the reactor, thus providing a scientifically sound way for scale-up and reactor characterization based on validated simulations. The presented approach can lead to a reduced time-to-market and the experimental load during scale-up and process transfer. SPONSORS PARTNERS CONTACT * Home * Register * Contact Type and Press “enter” to Search